[ATTACH]1387[/ATTACH]
Plenary II - AUA Town Hall 2015: Testosterone: Too Much or Not Enough?
Play Video ESP
Testosterone is Being Overprescribed and T Advertising is Inappropriate?
Panelist - Disagree: Martin M. Miner, MD
Panelist - Agree: Mark Sigman, MD
Play Video ESP
Age Discrimination or Age Specific Precautions: Will New Guidelines from the FDA Protect Elderly Male Patients or Condemn Them to Live with the Symptoms of Hypogonadism?
Panelist - Protect: Glenn R. Cunningham, MD
Panelist - Condemn: Adrian Dobs, MD
Play Video ESP
Testosterone Increases Cardiovascular Morbidity?
Panelist - Agree: Shehzad Basaria, MD
Panelist - Disagree: Mario Maggi, MD
Play Video ESP
Therapeutic Options and Best Practices in Management
Speaker: John P. Mulhall, MD
Play Video ESP
Erythrocytosis: Could This be the Key to Cardiovascular Risk?
Speaker: Wayne J.G. Hellstrom, MD
Play Video ESP
Anabolic Steroids, a Candid Conversation Between Patient and Physician
Speaker: Tobias S. Kohler, MD, MPH
Speaker: Chad Schaive
Play Video ESP
Androgen Town Hall: Expert Answers for the Urologic Community
Moderator: Ridwan Shabsigh, MD
Panelist: Arthur L. Burnett, II, MD
Panelist: Mark S. Hirsch, MD
Panelist: Mohit Khera, MD, MBA, MPH
Panelist: Mario Maggi, MD
Panelist: John P. Mulhall, MD
